TVM adds life science principal

TVM Capital has appointed Dr Kia Parssanedjad to its life science team, based in Munich. As a principal, he will be involved in deal origination and the evaluation of new investments, as well as research and support for existing portfolio companies with an emphasis on clinical development stage to commercial stage investments.

Parssanedjad completed medical studies at the University of Essen, Germany, at Harvard University, Boston, US and at St. Johns Medical College, Bangalore, India and holds a doctor degree for his molecular biological work in the field of gene therapy. Prior to joining TVM Capital, he worked as an engagement manager for McKinsey & Company, where he served pharmaceutical and private equity clients.